Table 4

Cumulative complication rates in the currently used GDDs

ComplicationsAhmed valve
(n=115)
Coleman 199526 Coleman 199743Coleman 199744
Krupin valve with disc
(n=75)
Krupin Study Group 199445
Fellenbaum 199424
Baerveldt implant
(n=249)
Lloyd 199448
Sidoti 199547
Smith 199351
Siegner 199546
Molteno implant
(n=395)
Mills 199639
Minckler 198842
Lloyd 199252
Heuer 199241
Hypotony/flat anterior chamber3.5%27%16.5%5%
Choroidal effusion/haemorrhage14%33%23%7%
Suprachoroidal haemorrhage3.5%1.3%0.8%0.5%
Hyphaema01.3%11%4%
Vitreous haemorrhage3.5%1.3%7%2%
Uveitis1.7%9.3%3.6%0.5%
Malignant glaucoma0.9%2.7%2%0.5%
Motility problem3.5%4%21%0.3%
CataractN/AN/A9.9% 12%
Tube blocked7.8%11%106%
Tube retraction5.2%2.7%2.4%0.8%
Tube/plate extrusion4.3%N/A1.20.5%
Tube/plate erosion02.7%23%
Corneal touch2.6%N/A4%3%
Corneal decompensation3.5%5.3%11.6%14%
Retinal detachment005%3.5%
Encepsulated bleb3.5%1.3%1.6%N/A
Phthisis01.3%2.4%4%
Others1.7% Wound leak1.3% Wound leak1.6% Wound leak0.3% Epiretinal membrane
1.3% Endophthalmitis0.4% Endophthalmitis0.3% Perforation
1.3% Decompression retinopathy
  • Cataract developed in 11 out of 91 phakic patients. Mean follow up more than 40 months.

  • Cataract developed in 7 out of 69 phakic patients. Mean follow up 14.4 months.